The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study (Q34059707)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study |
scientific article |
Statements
1 reference
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study (English)
1 reference
L R Molife
1 reference
P C Fong
1 reference
L Paccagnella
1 reference
A H M Reid
1 reference
H M Shaw
1 reference
L Vidal
1 reference
H-T Arkenau
1 reference
V Karavasilis
1 reference
T A Yap
1 reference
D Olmos
1 reference
J Spicer
1 reference
S Postel-Vinay
1 reference
D Yin
1 reference
A Lipton
1 reference
L Demers
1 reference
K Leitzel
1 reference
A Gualberto
1 reference
J S de Bono
1 reference
13 July 2010
1 reference
1 reference
103
1 reference
332-339
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference